term anticoagulation therapy to prevent surface clotting. Risks associated with anticoagulation therapy, such as bleeding or thromboembolism, are of concern to many patients. Although biologic tissue valves do not require anticoagulation therapy, their durability is limited by structural degeneration, calcification, or both. 1 It is unclear whether the degeneration of porcine valve prostheses is mediated by immune rejection. Porcine hearts transplanted into human subjects prompt a violent hyperacute rejection similar to that seen in ABO-incompatible transplantation in which the graft becomes cyanotic and edematous minutes after implantation. 2 The mechanism of porcine tissue rejection was elucidated in 1987, when Galili and colleagues 3 showed that human subjects constitutively synthesize immunoglobulin (Ig) M natural antibodies against a porcine endothelial molecule, galactose α-1,3-galactose (α-Gal). The extensive microvascular thrombosis of D iseased cardiac valves are replaced with either mechanical or biologic tissue prostheses. Mechanical valves are more durable but require longObjective: Transplanted porcine hearts are hyperacutely rejected by human immunoglobulin M antibodies against a porcine vascular endothelial molecule, galactose α-1,3-galactose, with ensuing human complement activation and membrane attack complex deposition. It is unclear, however, whether porcine valve endothelium triggers a similar immune response. We sought to investigate whether fresh porcine valves implanted into primates are rejected.
Methods: Wild-type porcine hearts before (n = 6) and after (n = 3) heterotopic transplantation into baboons underwent sectioning and were examined by hematoxylin and eosin staining and immunohistochemistry for galactose α-1,3-galactose, primate immunoglobulin M, and membrane attack complex.
Results: Examination of untransplanted porcine hearts showed that although cardiac microvascular endothelium strongly expressed the galactose α-1,3-galactose antigen, galactose α-1,3-galactose was not detected on the endothelium of porcine aortic and pulmonary valves. Porcine hearts transplanted into baboon recipients were hyperacutely rejected 60 to 80 minutes after implantation. Despite dramatic tissue damage associated with extensive immunoglobulin M and membrane attack complex binding on the microvascular endothelium, the aortic and pulmonary valves were entirely spared. Valves remained morphologically intact at explant and showed no signs of immunoglobulin M-and membrane attack complex-mediated damage. Because the mechanism of the human anti-pig immune response is now understood, we sought to determine whether human subjects mount a rejection response against fresh porcine valves. We suspected that valves may be immunologically distinct from heart tissue. Previously, Mitchell and colleagues 4 had shown that cardiac valves, even in rejected human heart transplants, rarely show any cellular infiltrate. Therefore, it may be possible that valves, as nonvascularized tissue, may be a low-visibility target for the immune system. The potential immune privilege of valve tissue suggests that porcine valve tissue may survive in human recipients. We thus sought to investigate the possibility of implanting fresh porcine valves. Fresh porcine valves contain viable endothelial and fibroblast cells, which can continuously repair leaflets undergoing hemodynamic stress and possibly confer better long-term durability. 5 To examine the immune reaction against fresh porcine valves, we performed heterotopic pig-tobaboon cardiac xenotransplantation. Relative expression of α-Gal antigens on vascular and valve endothelium was evaluated, and the degree of IgM and MAC deposition on valve leaflets was compared with that on cardiac microvasculature.
Material and methods
Experimental animals. Heterotopic pig-to-primate cardiac xenotransplantation was performed to test the immune reaction against fresh, unmanipulated, porcine valves. Olive baboons (Papio anubis) served as transplant recipients, whereas wild-type (Parson Farm) pigs served as heart donors. No immunosuppression was used for the study. All animals received humane care in accordance with the guidelines of the Harvard University Animal Care Committee and the "Guide for the Care and Use of Laboratory Animals" prepared by the Institute of Laboratory Animal Resources and published by the National Academy Press (National Academy Press publications No. xii-125, revised 1996). A B C out immunosuppression. The hearts became edematous, cyanotic, and engorged. Histologic examination of the rejected graft showed signs of thrombi, interstitial hemorrhage, and edema. There was extensive microvascular IgM (Fig 2, A) and MAC (Fig 2, B) deposition on the microvascular endothelium. Interestingly, both aortic and pulmonary valves were intact, and immunohistochemistry of pulmonary and aortic valves showed no signs of either IgM (Fig 2, C) or MAC (Fig 2, D) .
Discussion
The use of animal valve prostheses was first proposed and tested during the 1940s and 1950s. Although the exact immune barriers of animal-to-human tissue transplantation were not understood at that time, failures of organ transplantation convinced many that valve transplantation would suffer the same fate. Because of the difficult immunologic barriers of crossspecies transplantation, efforts were focused on preparing valves resistant to immune rejection. Fixatives were introduced not as a method of decreasing antigenicity but as a sterilizing and stiffening agent. In the first experimental article describing the transplantation of porcine valves, Duran and Gunning 8 mentioned that "the (porcine) graft was sterilized by immersion in liquid ethylene oxide." The other pioneers in the field, Binet and colleagues, 9 described "non-sterile pig and calf aortic valves obtained immediately after death at the slaughter house was at once placed in a mercurial solution" for 3 days. Only after that were the valves transferred into "sterile Gross's solution." The first reported use of formaldehyde on valves was to denature and stiffen elastic fibers in human homografts. 10 The first formaldehyde preservation of porcine valves was performed by O'Brien, 11 who used the solution in 1967 for "both preservation and sterilization." Both Hamilton and Gerbode 12 and Paneth and O'Brien 10 hypothesized that because formaldehyde "de-natures the proteins of the graft, [it] may minimize rejection phenomenon." However, there was no experiment or data to support this hypothesis.
A legacy of these early pioneers is glutaraldehydefixed porcine valves, which have successfully served as valve prostheses for the past 40 years. However, these valves degenerate because of hemodynamic stress and calcification. Fresh porcine valves may help to prevent both problems. Fresh valves contain viable endothelial and fibroblast cells, which may continue to repair and modify the leaflets undergoing hemodynamic stress and possibly confer better long-term durability. 5 Historically, fresh valves have not been seriously con- Anesthesia. For invasive procedures and anesthesia induction, sedation was achieved by using ketamine hydrochloride (10 mg/kg administered intramuscularly) in baboons and tiletamine hydrochloride and zolazepam hydrochloride (Telazol; 5 mg/kg administered intramuscularly) in pigs. Respiratory secretions were controlled with atropine sulfate (0.03 mg/kg). Anesthesia was maintained with inhalational isoflurane (1.3%-2.0%). Intraoperatively, both pigs and baboons were monitored with electrocardiography, noninvasive blood pressure monitoring, and pulse oximetry. All baboons received antibiotic coverage with cefazolin (Ancef; 20 mg/kg administered intramuscularly twice daily) and pain control with butrenorphine (Buprenex; 0.005 mg/kg administered twice daily) postoperatively for 5 days. In the event of diminished fluid or caloric intake, recipients received their calculated daily needs as intravenous crystalloid solution or Ensure tube feeds.
Heterotopic heart transplantation model. Heart transplantation was performed in the abdominal cavity, as previously described. 6 Pigs were anesthetized and received systemic anticoagulation with heparin (100 IU/kg administered intravenously), after which the heart was harvested in a standard fashion after protection by 500 mL of antegrade cold crystalloid cardioplegic solution (dextrose, 2.5%; sodium chloride, 0.45%; potassium, 30 mEq/L; and bicarbonate, 5 mEq/L). Transplant organ ischemic time varied between 45 and 55 minutes. The animals received no immunosuppression.
Histopathologic studies of the porcine valves. After graft explantation, aortic and pulmonary valves were carefully dissected and either snap-frozen in Tissue Freezing Medium (Triangle Biomedical Sciences, Durham, NC) and liquid nitrogen or fixed in Carnoy solution and embedded in paraffin. Paraffin sections were sectioned at 5-µm thickness and stained with hematoxylin and eosin. Biotinylated lectin from Griffonia simplicifolia (Sigma, St Louis, Mo) was used to stain α-Gal on porcine endothelium. Cryostat sections were immunostained by use of standard indirect immunoperoxidase avidin-biotin techniques, as previously summarized, 7 with monoclonal antibodies specific for IgM (Biodesign International, Kennebunk, Me) and MAC (C5-9; Dako, Carpinteria, Calif). The signal was developed with the avidinperoxidase system (ABC kit; Vector Lab, Burlingame, Calif).
Results
Endothelium of porcine valves and cardiac microvasculature. We examined untransplanted porcine hearts (n = 6) to characterize α-Gal expression on the endothelium of valve leaflets and cardiac microvasculature. Cardiac microvascular endothelium showed strong α-Gal expression (Fig 1, A) . In comparison, neither aortic valves (Fig 1, B) nor pulmonary valves (Fig 1, C) showed any detectable α-Gal expression.
Porcine valves in hyperacute rejection. Wild-type porcine xenografts (n = 3) were hyperacutely rejected 60 to 80 minutes after implantation into baboons with-templated as possible valve prostheses, mainly because of the assumption that all fresh porcine tissue, whether myocardium or cardiac valves, would undergo rejection.
In this report, however, we found that porcine valvular leaflets do not express α-Gal on their endothelium. The absence of detectable α-Gal on valvular leaflets may have protected porcine valves from IgM-mediated hyperacute rejection. Consequently, even though wildtype porcine cardiac xenografts were destroyed within 60 to 80 minutes of implantation by severe IgM and MAC deposition, aortic and pulmonary valves harvested from rejected xenografts showed no sign of damage.
The difference of α-Gal expression among different endothelial layers was not totally unexpected because we previously found that the endothelial cells of porcine cardiac microvasculature express α-Gal, whereas those of larger vessels do not. 7 Decreased α-Gal expression on valve endothelium could be due to either decreased glycosylation or decreased surface glycoproteins on leaflet endothelium. Protein expression is closely regulated in endothelial cells, and flow rate can clearly modulate endothelial gene expression. The expression of proteins, such as major histocompatibility complex antigen 13 and vascular cell adhesion molecule 1, 14 are all influenced by the amount of shear force exerted on the endothelium. Consequently, it is possible that shear force may also modulate other genes, such as the gal α-1,3-galactosyltransferase gene. The gal α-1,3-galactosyltransferase protein glycosylates the α-Gal terminal sugar to surface proteins, 15 and its expression is tightly controlled in the porcine endothelium. For example, inflammatory cytokines, such as tumor necrosis factor α and lipopolysaccharide, decrease the level of gal α-1,3-galactosyltransferase protein. Consequently, it is possible that differential shear forces exerted on cardiac 
